Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Viracta Therapeutics Ord Shs (VIRX)  
$0.77 0.01 (1.45%) as of 4:30 Mon 5/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 37,090,000
Market Cap: 28.60(M)
Last Volume: 1,764,528 Avg Vol: 1,759,649
52 Week Range: $0.439 - $2.125
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Viracta Therapeutics is a precision oncology company focused on the development of medicines targeting virus-associated malignancies. Co.'s main program is focused on cancers associated with the Epstein-Barr virus (EBV). Co.'s main product candidate is an all-oral combination therapy of its investigational drug, nanatinostat and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is being investigated in clinical trials, including NAVAL-1, a trial for the treatment of multiple subtypes of relapsed/refractory EBV-positive (EBV+) lymphoma, as well as a trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 100,000 100,000 100,000
Total Buy Value $0 $49,361 $49,361 $49,361
Total People Bought 0 1 1 1
Total Buy Transactions 0 2 2 2
Total Shares Sold 3,405 7,125 14,272 63,811
Total Sell Value $2,493 $4,353 $14,605 $152,715
Total People Sold 1 1 1 3
Total Sell Transactions 1 2 4 14
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 163
  Page 7 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bay City Capital Fund V Co-Investment Fund Lp 10% Owner   –       –       •   2014-08-11 4 S $6.90 $218,103 D/D (31,600) 4,931,487     -
   Misfeldt Dayton Director   –       •       •   2014-08-11 4 S $6.90 $218,103 I/I (31,600) 92,189     -
   Baskett Forest 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Bay City Capital Fund V Co-Investment Fund Lp 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 D/D (675,000) 4,963,087     -
   Misfeldt Dayton Director   –       •       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 92,780     -
   Sandell Scott D 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Kolluri Krishna Kittu 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Kerins Patrick J 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Drant Ryan D 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Nea 12 Gp, Llc 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 D/D (675,000) 4,961,573     -
   Barrett M James 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Barris Peter J 10% Owner   –       –       •   2014-08-08 4 S $6.62 $4,468,568 I/I (675,000) 4,961,573     -
   Swisher Daniel N Jr President and CEO   •       •      –    2014-05-16 4 OE $2.09 $50,973 D/D 24,389 152,406     -
  163 Records found
  1  2  3  4  5  6  7    
  Page 7 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us